2021-01-04,Bellerophon to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference
2020-12-01,Bellerophon Therapeutics Announces First Patient Enrolled in Phase 3 REBUILD Study Evaluating INOpulse® for the Treatment of Fibrotic Interstitial Lung Disease
2020-11-28,"Here is What Hedge Funds Think About Bellerophon Therapeutics, Inc. (BLPH)"
2020-11-23,Bellerophon Therapeutics Announces Results of Interim Analysis of Phase 3 COViNOX Study of INOpulse® for the Treatment of COVID-19
2020-11-11,Bellerophon to Present at the H.C. Wainwright 6th Annual Israel Conference
2020-11-05,"Bellerophon Therapeutics (BLPH) Reports Q3 Loss, Lags Revenue Estimates"
2020-11-05,Bellerophon Provides Clinical Program Update and Reports Third Quarter 2020 Financial Results
2020-10-29,Bellerophon to Present Results from its Phase 2 iNO-PF Study of INOpulse® for the Treatment of Fibrotic Interstitial Lung Disease at Upcoming Scientific Conferences
2020-09-14,Insider Buys Bellerophon Therapeutics Shares
2020-09-14,Bellerophon to Present at Two September Investor Conferences
2020-08-11,"Bellerophon Appoints Cardiopulmonary Disease Expert Wassim Fares, M.D., MSCR, as Chief Medical Officer"
2020-08-05,Bellerophon Provides Clinical Program Update and Reports Second Quarter 2020 Financial Results
2020-07-15,Bellerophon Therapeutics Announces Publication of Cohort 1 of iNO-PF Phase 2/3 Study in the CHEST Journal and Participation in Webinar to Discuss Clinical Results
2020-07-13,Bellerophon Therapeutics Announces First Patient Treated in Phase 3 Clinical Study of INOpulse® Inhaled Nitric Oxide Therapy for COVID-19
2020-06-29,Bellerophon Therapeutics Added to Russell 3000® and Microcap® Indexes
2020-06-04,"Is Bellerophon Therapeutics, Inc. (BLPH) A Good Stock To Buy?"
2020-05-29,Alan Fournier Adds 4 Stocks to Portfolio
2020-05-22,Bellerophon Therapeutics Announces Closing of $43.7 Million Public Offering of Common Stock and Concurrent Registered Direct Offering and Full Exercise of Option to Purchase Additional Shares
2020-05-19,8 Biotechs Tapping Secondary Markets for $3 Billion
2020-05-19,Bellerophon Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Registered Direct Offering
2020-05-18,Bellerophon Therapeutics Announces Proposed Public Offering of Common Stock
2020-05-12,"Company News for May 12, 2020"
2020-05-11,Bellerophon Provides Clinical Program Update and Reports First Quarter 2020 Financial Results
2020-05-11,Bellerophon Therapeutics Announces FDA Clears Initiation of Phase 3 Study for INOpulse® Inhaled Nitric Oxide Therapy to Treat COVID-19
2020-05-04,Bellerophon Therapeutics to Participate in COVID-19 Panel at Maxim Groups Infectious Disease Virtual Conference
2020-04-17,These experimental drugs may help keep COVID-19 patients off ventilators
2020-04-08,Covid-19: Could Bellerphon Therapeutics INOpulse Help Address Hospital Ventilator Shortage?
2020-04-08,Bellerophon Therapeutics Submits Investigational New Drug Application to Study INOpulse® Inhaled Nitric Oxide Therapy for the Treatment of COVID-19
2020-04-06,Bellerophon Provides Clinical Program Update and Reports Fourth Quarter and Full-Year 2019 Financial Results
2020-04-01,Bellerophon Announces Closing of $15.3 Million Registered Direct Offering of Common Stock
2020-03-31,Bellerophon Therapeutics to Host Investor Call and Webcast Today on INOpulse® for the Treatment of COVID-19
2020-03-30,Bellerophon Announces $15.3 Million Registered Direct Offering Priced At-the-Market
2020-03-30,Bellerophon Therapeutics Announces First Patient Treated with INOpulse® Inhaled Nitric Oxide Therapy for COVID-19
2020-03-29,Bellerophon Shares Jump On Covid-19 OK
2020-03-23,"Company News for Mar 23, 2020"
2020-03-22,3 Coronavirus Stocks with Over 60% Upside
2020-03-20,FDA Grants Bellerophon Emergency Expanded Access for INOpulse® for the Treatment of COVID-19 Virus
2020-03-10,Bellerophon Announces Agreement with the FDA on its Planned Pivotal Phase 3 Study for the Treatment of Pulmonary Hypertension Associated with Pulmonary Fibrosis
2020-02-21,The One Metric That Helps Me Find Stocks With The Greatest Potential
2020-02-19,"Company News for Feb 19, 2020"
2020-02-19,"Biotech Stock Roundup: INCY's Solid Q4 Results, EPZM & SGEN's Pipeline Updates"
2020-02-19,"The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA"
2020-02-18,Bellerophon Reports Positive Top-Line Data from an Ancillary Acute Hemodynamic Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Pulmonary Fibrosis
2020-02-07,Bellerophon Announces 1-for-15 Reverse Stock Split
2019-12-20,"Is Bellerophon Therapeutics, Inc. (BLPH) Going to Burn These Hedge Funds?"
2019-12-17,Bellerophon stock is up 35% on hypertension trial data
2019-12-17,Bellerophon Announces Positive Top-line Results from Cohort 2 of Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
2019-11-12,Bellerophon Announces Positive Initial Data from Acute Hemodynamic Dose Escalation Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
2019-11-07,Bellerophon Presents New Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at Pulmonary Fibrosis Foundation Summit 2019
2019-11-06,Bellerophon Provides Business Update and Reports Third Quarter 2019 Financial Results
2019-11-01,Largest Insider Trades of the Week
2019-10-28,"BLPH: More Clinical Data Supports Utility of INOpulse, Near-Term Value-Inflection Opportunities Grow"
2019-10-23,Bellerophon Presents New Positive Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at CHEST 2019 Annual Meeting
2019-10-23,"The Daily Biotech Pulse: Eli Lily Revenues Trail Estimates, Moderna Gets Fast Track Designation, MacroGenics' Lukewarm Breast Cancer Data"
2019-10-20,"The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict"
2019-10-14,Bellerophon to Present New Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at CHEST 2019 Annual Meeting
2019-09-16,Bellerophon Receives Orphan Drug Designation for Nitric Oxide in the Treatment of Idiopathic Pulmonary Fibrosis
2019-09-04,Bellerophon to Present at the H.C. Wainwright 21st Annual Global Investment Conference
2019-08-08,"Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) Insiders Increased Their Holdings"
2019-08-08,Bellerophon Provides Business Update and Reports Second Quarter 2019 Financial Results
2019-08-06,BLPH: Zacks SCR Initiates Coverage of Bellerophon Therapeutics
2019-08-01,Bellerophon Completes Enrollment in Cohort 2 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
2019-06-13,Bellerophon to Present at the JMP Securities Life Sciences Conference
2019-05-22,Bellerophon to Host Key Opinion Leader Meeting Focused on Pulmonary Hypertension Associated with Interstitial Lung Disease
2019-05-21,Bellerophon Presents Additional Positive Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at American Thoracic Society 115th International Conference
2019-05-18,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs"
2019-05-13,Bellerophon to Present Additional Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at American Thoracic Society 115th International Conference
2019-05-09,Bellerophon Therapeutics: 1Q Earnings Snapshot
2019-05-09,Bellerophon Provides Business Update and Reports First Quarter 2019 Financial Results
2019-05-03,"What Kind Of Shareholders Own Bellerophon Therapeutics, Inc. (NASDAQ:BLPH)?"
2019-04-08,Bellerophon Announces Agreement with FDA on Regulatory Approval Pathway for INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
2019-03-18,Did Changing Sentiment Drive Bellerophon Therapeuticss (NASDAQ:BLPH) Share Price Down A Painful 76%?
2019-03-14,Bellerophon Therapeutics: 4Q Earnings Snapshot
2019-03-14,Bellerophon Provides Business Update and Reports Fourth Quarter and Full-Year 2018 Financial Results
2019-01-28,Bellerophon to Present Clinical Data Supporting Actigraphy as a Clinically Meaningful Endpoint to Detect Improvements in Pulmonary Fibrosis Patients
2019-01-25,Bellerophon Announces Closing of $7 Million Public Offering of Common Stock
2019-01-23,Bellerophon Announces Pricing of $7 Million Public Offering of Common Stock
2019-01-22,"Bellerophon Therapeutics, Inc. Announces Proposed Public Offering of Common Stock"
2019-01-07,Bellerophon Announces Top-line Results from Cohort 1 of the INOpulse® Phase 2b Clinical Trial for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
2018-11-21,"Analysis: Positioning to Benefit within KemPharm, Bellerophon Therapeutics, Exela Technologies, Intec Pharma, Cerecor, and Chiasma  Research Highlights Growth, Revenue, and Consolidated Results"
2018-11-16,DBV Technologies Appoints Daniel Tassé as Chief Executive Officer
2018-11-07,Bellerophon Therapeutics: 3Q Earnings Snapshot
2018-11-07,Bellerophon Provides Business Update and Reports Third Quarter 2018 Financial Results
2018-10-09,Bellerophon Provides Update on INOpulse® Phase 2b Clinical Program for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
2018-09-10,3 Biotech & Marijuana Stocks to Pay Attention to this Quarter
2018-08-29,Bellerophon Therapeutics to Present at Rodman & Renshaw 20th Annual Global Investment Conference
2018-08-20,Todays Research Reports on Stocks to Watch:Tesla and Bellerophon Therapeutics
2018-08-08,"The Daily Biotech Pulse: FDA Panel Backs Insmed, Eidos' Maiden Earnings, Paratek Awaits Adcom Verdict"
2018-08-07,Bellerophon Announces Results of Interim Analysis of Phase 3 INOvation-1 Study Evaluating INOpulse® for Treatment of Pulmonary Arterial Hypertension
2018-08-01,Bellerophon Therapeutics: 2Q Earnings Snapshot
2018-08-01,Bellerophon Provides Business Update and Reports Second Quarter 2018 Financial Results
2018-06-15,5 Biotech Stocks Under $10 Worthy of Investors' Attention
2018-06-12,"The Zacks Analyst Blog Highlights: Comtech Telecommunications, Echo Global Logistics, Shoe Carnival, Bellerophon Therapeutics and OFG Bancorp"
2018-06-12,Bellerophon Therapeutics to Participate on Panel at JMP Securities Life Sciences Conference
2018-06-11,5 Top-Ranked Small Caps to Buy as Trade Tensions Escalate
2018-06-11,Bet on 5 Top-Ranked Small Caps as Trade Tensions Escalate
2018-05-16,Bellerophon to Present Positive Results from Phase 2 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease at the American Thoracic Society 114th International Conference
2018-05-10,Bellerophon Provides Business Update and Reports First Quarter 2018 Financial Results
2018-05-08,Bellerophon Reaches Agreement with FDA on Study Design of Phase 2b Trial of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease
2018-04-30,Exact Sciences (EXAS) in Focus: Stock Moves 11.6% Higher
